HIV

Combine

Pharma

Merck-Gilead first-of-its-kind combo pill scores in 2 HIV trials

A combo pill from Merck and Gilead has succeeded in two phase 3 trials and is set up to become the first oral HIV treatment that can be taken weekly.

Kevin Dunleavy Jun 9, 2026 11:20am

Gilead

Gilead says long-acting PrEP Yeztugo in line for $1B in '26 sales

May 8, 2026 11:30am

merck

FDA signs off on Merck's HIV combo pill Idvynso

Apr 21, 2026 3:26pm

Gilead Yeztugo injection

MSF decries Gilead's updated global access plan for Yeztugo

Apr 15, 2026 12:14pm

ViiV still here

ViiV Healthcare launches ‘Still Here’ HIV campaign

Apr 13, 2026 8:47am

Gilead Sciences Yeztugo HIV PrEP

Manufacturing is key to Gilead's Yeztugo PrEP rollout: exec

Mar 13, 2026 10:33am